Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Current Clinical Issues"'
Publikováno v:
Journal of Oncology Practice. 7:117-121
Journal of Clinical Oncology recently published ASCO's update to its guideline on the use of bone-modifying agents for patients with bone metastases, the scope of which was narrowed to the use of bone-modifying agents for patients with evidence of bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a64f4b300586e0ea5c300046a45f988
https://doi.org/10.1200/jop.2011.000212
https://doi.org/10.1200/jop.2011.000212
Autor:
Patricia Hurley, Mark R. Somerfield, Sarah Temin, J. Douglas Rizzo, Melissa C. Brouwers, Jerome Seidenfeld
Publikováno v:
Journal of Oncology Practice. 6:317-320
This guideline update addresses two clinical questions: (1) What are the defining features of patients with a malignancy who are appropriate candidates for ESA treatment? (2) For patients who are appropriate candidates for treatment with ESAs, what a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c47344a4abccccf7f0abc43e6989ee
https://doi.org/10.1200/jop.2010.000132
https://doi.org/10.1200/jop.2010.000132
Publikováno v:
Journal of Oncology Practice. 6:243-246
ASCO's technology assessment of the use of aromatase inhibitors in the adjuvant setting was last updated in 2004. ASCO's Update Committee on Aromatase Inhibitors reconvened in May 2009 to update this guideline.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9012d89599a67cbe8530d93efe85e0a8
https://doi.org/10.1200/jop.000082
https://doi.org/10.1200/jop.000082
ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
Publikováno v:
Journal of Oncology Practice. 6:199-202
An examination of serum tumor markers for monitoring or surveillance for each histologic germ cell tumor subtype: seminoma and nonseminomatous germ cell tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05841df1c3572b0b436f6e5e55525798
https://doi.org/10.1200/jop.777010
https://doi.org/10.1200/jop.777010
Autor:
Kenneth V. I. Rolston, Gary H. Lyman
Publikováno v:
Journal of Oncology Practice. 6:149-152
Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd762df5b3b878daf8d8479eb8d720c
https://doi.org/10.1200/jop.091092
https://doi.org/10.1200/jop.091092
Autor:
Alan E. Lichtin, David Cella, Charles L. Bennet, Ann A. Jakubowski, Julia Bohlius, Matthew J. Goode, David H. Regan, Douglas Rizzo, Mark U. Rarick, Benjamin Djullbegovic, Jerome Seidenfeld, Karen L. Hagerty, Mark R. Somerfield
Publikováno v:
Journal of Oncology Practice. 4:48-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41fe5dc08bacf22e9a4d5e4c824e7fc0
https://doi.org/10.1200/jop.0818502
https://doi.org/10.1200/jop.0818502
Autor:
Laurie E. Gaspar, Christopher E. Desch, David R. Spigel, Mark G. Kris, Christopher A. Smith, William K. Evans, Peter M. Ellis, Christopher G. Azzoli, Harvey I. Pass, Mark R. Somerfield, Frances A. Shepherd, John R. Strawn, Gail Darling, Melissa C. Brouwers, Yee C. Ung, Katherine M.W. Pisters
Publikováno v:
Journal of Clinical Oncology. 25:5506-5518
Purpose To determine the role of adjuvant chemotherapy and radiation therapy in patients with completely resected stage IA-IIIA non–small-cell lung cancer (NSCLC). Methods The Cancer Care Ontario Program in Evidence-Based Care and the American Soci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23d717556ff3fd47c00c9cf0ccb8c10
https://doi.org/10.1200/jco.2007.14.1226
https://doi.org/10.1200/jco.2007.14.1226
Autor:
Sheila E. Taube, Daniel F. Hayes, Herbert A. Fritsche, Mark R. Somerfield, Robert C. Bast, Lyndsay Harris, Robert G. Mennel, Larry Norton, Peter M. Ravdin
Publikováno v:
Journal of Clinical Oncology. 25:5287-5312
PurposeTo update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer.MethodsFor the 2007 update, an Update Committee composed of members from the full Panel was formed to co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0c7be0a1b30a49d87770487cbb9f7d
https://doi.org/10.1200/jco.2007.14.2364
https://doi.org/10.1200/jco.2007.14.2364
Publikováno v:
Journal of Oncology Practice. 6:195-197
ASCO and CAP collaborated to produce an evidence-based guideline on estrogen and progesterone receptor testing in breast cancer to produce optimal testing performance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a0ea78cd182dbfe44d85ba9d19fcc9e
https://doi.org/10.1200/jop.777003
https://doi.org/10.1200/jop.777003
Autor:
David Joseph Debono
Publikováno v:
Journal of Oncology Practice. 6:203-205
An effective response to the impending shortage of oncology services will require different actions from governmental bodies, academic cancer center leaders, medical societies, and community oncology providers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24847ba27f5f699a7862345d386e4aff
https://doi.org/10.1200/jop.777005
https://doi.org/10.1200/jop.777005